TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
QNCX

Quince Therapeutics, Inc.

Healthcare · Biotechnology

27.00$ -0.6% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Quince Therapeutics, Inc. (QNCX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 66.8% of the shares are freely tradable; institutional investors hold 17.1%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 17.1%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 0.4%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 66.8%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 5.6%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 1Mio.

Largest Shareholders

Institutions

Institutions QNCX
Name Stake (%) Shares Change (%) Date
Woodline Partners LP 2.56 5,200,000 +167.8 03/31/2026
Shay Capital LLC 0.87 1,772,909 +0.0 03/31/2026
Acadian Asset Management LLC 0.86 1,750,862 +0.0 03/31/2026
Millennium Management LLC 0.35 70,779 +465.4 06/30/2026
IEQ CAPITAL, LLC 0.30 600,105 -38.7 03/31/2026
BlackRock Inc 0.23 473,259 +0.3 03/31/2026
Vanguard Capital Management, LLC 0.23 461,477 +0.0 03/31/2026

Funds

Funds QNCX
Name Stake (%) Shares Change (%) Date
Vanguard Institutional Extnd Mkt Idx Tr 1.18 12,045 +0.0 07/31/2026
Fidelity Extended Market Index 0.43 4,341 -0.2 07/31/2026
Fidelity Series Total Market Index 0.25 2,513 +624.2 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?